184 related articles for article (PubMed ID: 17768668)
41. Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up.
Gabrielli O; Clarke LA; Bruni S; Coppa GV
Pediatrics; 2010 Jan; 125(1):e183-7. PubMed ID: 20026495
[TBL] [Abstract][Full Text] [Related]
42. Mucopolysaccharidosis I under enzyme replacement therapy with laronidase--a mortality case with autopsy report.
Lin HY; Lin SP; Chuang CK; Chen MR; Chen BF; Wraith JE
J Inherit Metab Dis; 2005; 28(6):1146-8. PubMed ID: 16435211
[TBL] [Abstract][Full Text] [Related]
43. Sudden vision loss in a mucopolysaccharidosis I patient receiving enzyme replacement therapy.
Yosunkaya E; Karaca E; Yilmaz SB; Gezdirici A; Guven G; Seven M; Yuksel A
Genet Couns; 2011; 22(4):371-6. PubMed ID: 22303797
[TBL] [Abstract][Full Text] [Related]
44. Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I.
Tokic V; Barisic I; Huzjak N; Petkovic G; Fumic K; Paschke E
Eur J Pediatr; 2007 Jul; 166(7):727-32. PubMed ID: 17043838
[TBL] [Abstract][Full Text] [Related]
45. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.
de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA
Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279
[TBL] [Abstract][Full Text] [Related]
46. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
[TBL] [Abstract][Full Text] [Related]
47. Life-threatening pulmonary hemorrhages post bone marrow transplantation in Hurler syndrome. Report of three cases and review of the literature.
Gassas A; Sung L; Doyle JJ; Clarke JT; Saunders EF
Bone Marrow Transplant; 2003 Jul; 32(2):213-5. PubMed ID: 12838287
[TBL] [Abstract][Full Text] [Related]
48. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.
Wraith JE
Expert Opin Pharmacother; 2005 Mar; 6(3):489-506. PubMed ID: 15794739
[TBL] [Abstract][Full Text] [Related]
49. [Outcome of two patients with Hurler's syndrome under enzyme replacement therapy with human recombinant alpha-L-iduronidase].
Sardón O; García Pardos C; Mintegui J; Pérez Ruiz E; Coll MJ; Chabás A; Olivé T; Ruiz Benito A
An Pediatr (Barc); 2005 Jul; 63(1):61-7. PubMed ID: 15989873
[TBL] [Abstract][Full Text] [Related]
50. Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function.
Pillai NR; Elsbecker SA; Gupta AO; Lund TC; Orchard PJ; Braunlin E
Mol Genet Metab; 2023 Nov; 140(3):107669. PubMed ID: 37542767
[TBL] [Abstract][Full Text] [Related]
51. Fatal coronary artery disease in an infant with severe mucopolysaccharidosis type I.
van den Broek L; Backx AP; Coolen H; Wijburg FA; Wevers R; Morava E; Neeleman C
Pediatrics; 2011 May; 127(5):e1343-6. PubMed ID: 21464194
[TBL] [Abstract][Full Text] [Related]
52. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).
Wraith JE; Clarke LA; Beck M; Kolodny EH; Pastores GM; Muenzer J; Rapoport DM; Berger KI; Swiedler SJ; Kakkis ED; Braakman T; Chadbourne E; Walton-Bowen K; Cox GF
J Pediatr; 2004 May; 144(5):581-8. PubMed ID: 15126990
[TBL] [Abstract][Full Text] [Related]
53. Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study.
Chen AH; Harmatz P; Nestrasil I; Eisengart JB; King KE; Rudser K; Kaizer AM; Svatkova A; Wakumoto A; Le SQ; Madden J; Young S; Zhang H; Polgreen LE; Dickson PI
Mol Genet Metab; 2020 Feb; 129(2):80-90. PubMed ID: 31839529
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcome of Hurler syndrome following bone marrow transplantation.
Whitley CB; Belani KG; Chang PN; Summers CG; Blazar BR; Tsai MY; Latchaw RE; Ramsay NK; Kersey JH
Am J Med Genet; 1993 Apr; 46(2):209-18. PubMed ID: 8484412
[TBL] [Abstract][Full Text] [Related]
55. Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous enzyme post-transplant: a case report.
Soni S; Hente M; Breslin N; Hersh J; Whitley C; Cheerva A; Bertolone S
Pediatr Transplant; 2007 Aug; 11(5):563-7. PubMed ID: 17631030
[TBL] [Abstract][Full Text] [Related]
56. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.
Sifuentes M; Doroshow R; Hoft R; Mason G; Walot I; Diament M; Okazaki S; Huff K; Cox GF; Swiedler SJ; Kakkis ED
Mol Genet Metab; 2007 Feb; 90(2):171-80. PubMed ID: 17011223
[TBL] [Abstract][Full Text] [Related]
57. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
[TBL] [Abstract][Full Text] [Related]
58. Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease.
Hsu YH; Liu RS; Lin WL; Yuh YS; Lin SP; Wong TT
Orphanet J Rare Dis; 2017 Jun; 12(1):109. PubMed ID: 28595620
[TBL] [Abstract][Full Text] [Related]
59. [Enzyme replacement therapy of lysosomal storage diseases].
Germain DP; Boucly C; Carlier RY; Caudron E; Charlier P; Colas F; Jabbour F; Martinez V; Mokhtari S; Orlikowski D; Pellegrini N; Perronne C; Prigent H; Rubinsztajn R; Benistan K
Rev Med Interne; 2010 Dec; 31 Suppl 2():S279-91. PubMed ID: 21211680
[TBL] [Abstract][Full Text] [Related]
60. [Mucopolysaccharidosis I, Hurler syndrome: a case report].
Amorín M; Carlin A; Prötzel A
Arch Argent Pediatr; 2012 Oct; 110(5):e103-6. PubMed ID: 23070190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
